Tempus AI, Inc.
TEM Healthcare Health Information Services
Tempus AI, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.3 billion, up 83.4% from fiscal 2024.
- Revenue
- +23.1%
- EPS
- +82.2%
- Free cash flow
- +95.7%
- Total debt
- +8.44%
Quarter to September 2026, against a year earlier
Follow TEM
Alert me
Tempus AI, Inc. (TEM) Total debt
Tempus AI, Inc.'s total debt at the end of fiscal 2025 was $1.2B, up 184.7% from $435.4M in fiscal 2024. At the end of the quarter to 30 September 2026 it was $1.4B. Tempus AI, Inc. ranks 4th of 42 Health Information Services companies by total debt.
Total debt, annual
Embed this chart
Annual newest first
| Period | Total debt | Change |
|---|---|---|
| FY2025 | $1.2B | 184.66% |
| FY2024 | $435.4M | (3.16%) |
| FY2023 | $449.7M | 15.43% |
| FY2022 | $389.5M | — |
Quarterly newest first
| Period | Total debt | Change |
|---|---|---|
| Sep 2026 | $1.4B | (0.73%) |
| Jun 2026 | $1.4B | 10.34% |
| Mar 2026 | $1.2B | (0.51%) |
| Dec 2025 | $1.2B | (0.50%) |
| 9 more quarters | Free account |
Total debt against peers
| Company | Total debt |
|---|---|
| BTSG BrightSpring Health Services, Inc. compare | $2.2B |
| WAY Waystar Holding Corp. compare | $1.5B |
| TEM Tempus AI, Inc. | $1.4B |
| HQY HealthEquity, Inc. compare | $931.1M |
| HTFL Heartflow, Inc. compare | $182.4M |
| VEEV Veeva Systems Inc. compare | $58.0M |
| DOCS Doximity, Inc. compare | $15.0M |
| PRVA Privia Health Group, Inc. compare | $5.8M |
| HNGE Hinge Health Inc. compare | — |
What Total debt is
Total Debt tells an investor how much a company has borrowed in all, whether the money is due within a year or later.
Long Term Debt (Total) + Current Part of Debt
More on TEM
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Shares outstanding
- Book value per share
- Revenue growth
- Beneish M-score
- The full statement